Realcan Pharmaceutical Group Co., Ltd. (SZSE: 002589)
Health Care · Health Care Providers & Services · CN
CN¥3.35
+2.45% today · +17.1% 1Y
Realcan Pharmaceutical Group Co., Ltd. (SZSE: 002589) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $735.24M and employs 2,407 people.
Over the last twelve months the share price has gained 17.1%, trading between 2.38 and 4.69.
Tweenvest scores Realcan Pharmaceutical Group Co., Ltd. across four factors: quality 54/100, value 32/100, growth 0/100, dividend 36/100. Its strongest factor is quality.
002589 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $735.24M
- Revenue (TTM)
- $1.06B
- P/E
- —
- EPS
- 0.01
- Dividend yield
- 0.06%
- Beta (5Y)
- 0.24
- 52-week high
- CN¥4.69
- 52-week low
- CN¥2.38
- Avg volume (3M)
- —
- Shares outstanding
- 1.47B
- Employees
- 2,407
- Next earnings
- —
About Realcan Pharmaceutical Group Co., Ltd.
Realcan Pharmaceutical Group Co., Ltd. operates as a global supplier, distributing pharmaceuticals, vaccines, medical devices, and consumable medical products to healthcare institutions across the world. Beyond its core distribution activities, the company offers a suite of specialized services, including comprehensive medical logistics, third-party logistics solutions, disinfection and sterilization, and equipment leasing, alongside full-service hospital logistics support. Its operational reach spans diverse areas such as drug distribution, academic support services, medical diagnostics, financial technology applications, traditional Chinese medicine, digital health solutions, professional logistics, and integrated equipment management. The company, initially incorporated as Realcan Pharmaceutical Co., Ltd., adopted its current designation in December 2018. Realcan was established in 2004 and is headquartered in Yantai, China.
- ISIN
- CNE1000013X5
- Founded
- 2004
- Listed since
- Jun 10, 2011
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jinxin Fertility Group LimitedSEHK: 1951 | $763.54M | HK$2.29 | +6.51% |
| Entero Healthcare Solutions LimitedNSEI: ENTERO | $753.80M | Rs1,676.20 | -0.27% |
| Hygeia Healthcare Holdings Co., LimitedSEHK: 6078 | $743.20M | HK$9.61 | +1.26% |
| WELL Health Technologies Corp.TSX: WELL | $742.64M | CA$4.14 | -3.94% |
| Gushengtang Holdings LimitedSEHK: 2273 | $721.81M | HK$26.74 | +0.83% |
| Amal Holdings A.D. Ltd.TASE: AMAL | $714.78M | ₪15.64 | -1.64% |
| PT Metro Healthcare Indonesia TbkIDX: CARE | $702.39M | Rp378.00 | +1.61% |
| Shanghai Labway Clinical Laboratory Co., LtdSZSE: 301060 | $700.88M | CN¥11.78 | -2.00% |
Figures last refreshed Oct 11, 2026.